← Leaderboards
Jun Chung
Louisiana State Univ Hsc Shreveport
$1,576,081
Attributed
$1,576,081
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $327.9K · FY2013–17$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,576,081 · 1
By mechanism
R01$1,576,081 · 1
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ Hsc Shreveport
Same institution · by research overlap
- Lynn Harrison$3,188,042
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoKinetinsAffectIn VitroBreast Cancer CellIn Vivo ModelBreast Cancer ModelBaseCellsAggressive BehaviorComplexDrug CompoundingEpigenetic ProcessArrestinsEstrogensEventFeedbackGrowthHemidesmosomesHistone DeacetylaseHormonesIntegrin Beta4IntegrinsLink
Grant awards (6)
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$327,850
R01 · FY2017 · CA · contact PI
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$327,850
R01 · FY2016 · CA · contact PI
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$262,176
R01 · FY2015 · CA · contact PI
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$61,518
R01 · FY2015 · CA · contact PI
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$297,887
R01 · FY2014 · CA · contact PI
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer$298,800
R01 · FY2013 · CA · contact PI